Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 292
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02145039 | Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases | ||
| NCT02670837 | Study of Cellutome System for Treatment of Individual Lesions in EB Pts | ||
| NCT05809557 | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | ||
| NCT01626092 | Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders | ||
| NCT05973656 | Role of Acetaldehyde in the Development of Oral Cancer | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT02693665 | Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer | ||
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | ||
| NCT02309944 | Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients | ||
| NCT03365661 | QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML | ||
| NCT00281827 | Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer | ||
| NCT04284254 | MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT | ||
| NCT00258427 | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia | ||
| NCT03934840 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | ||
| NCT05502302 | App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer | ||
| NCT02074631 | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | ||
| NCT00176904 | Stem Cell Transplant for Inborn Errors of Metabolism | ||
| NCT03728699 | Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy | ||
| NCT03152526 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR | ||
| NCT00000105 | Vaccination With Tetanus and KLH to Assess Immune Responses. | ||
| NCT06295757 | Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures | ||
| NCT00309842 | Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases | ||
| NCT01171469 | Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor | ||
| NCT03383055 | CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT03367546 | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT01560923 | Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer | ||
| NCT01850888 | MIBG for Refractory Neuroblastoma and Pheochromocytoma | ||
| NCT02722668 | UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep | ||
| NCT01043640 | Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders | ||
| NCT00602693 | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | ||
| NCT02118285 | Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT00855114 | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery | ||
| NCT02845414 | Study of CD133KDEL Toxin in the Treatment for Solid Tumors | ||
| NCT00612716 | Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia | ||
| NCT00432094 | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | ||
| NCT01666080 | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) | ||
| NCT00258362 | Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer | ||
| NCT00305682 | Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant | ||
| NCT00871689 | Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML | ||
| NCT04003805 | Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users | ||
| NCT00609739 | Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation | ||
| NCT00428194 | Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer | ||
| NCT06342986 | Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT05447156 | QuitGuide for American Indians: Aims 2 & 3 | ||
| NCT00686556 | Total Marrow Irradiation for Refractory Acute Leukemia | ||
| NCT01451502 | Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units | ||
| NCT02171104 | MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis | ||
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors |
